SOLENO THERAPEUTICS INC (SLNO) Stock Analyst Ratings
USA - NASDAQ:SLNO - US8342033094 - Common Stock
48.54 USD
+1.29 (+2.73%)
48.4 USD
-0.14 (-0.29%)
ChartMill assigns a Buy % Consensus number of 86% to SLNO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 121.38. This target is 150.06% above the current price.
SLNO was analyzed by 18 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SLNO.
In the previous month the buy percentage consensus was at a similar level.
SLNO was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-18 | Wolfe Research | Initiate | Outperform |
| 2025-11-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-27 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-08-20 | Wells Fargo | Initiate | Overweight |
| 2025-08-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-07 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-11 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-08 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-08 | Baird | Maintains | Outperform -> Outperform |
| 2025-04-24 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-28 | Guggenheim | Maintains | Buy -> Buy |
| 2025-03-28 | Stifel | Maintains | Buy -> Buy |
| 2025-03-27 | Laidlaw & Co. | Maintains | Buy -> Buy |
| 2025-03-27 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-03-27 | Baird | Maintains | Outperform -> Outperform |
| 2025-03-05 | Stifel | Reiterate | Buy |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-02 | Baird | Reiterate | Outperform -> Outperform |
| 2024-12-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-01 | Stifel | Maintains | Buy -> Buy |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-03 | HC Wainwright & Co. | Initiate | Buy |
| 2024-08-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-07-31 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-13 | Oppenheimer | Maintains | Outperform -> Outperform |
SOLENO THERAPEUTICS INC / SLNO FAQ
What is the price target for SLNO stock?
18 analysts have analysed SLNO and the average price target is 121.38 USD. This implies a price increase of 150.06% is expected in the next year compared to the current price of 48.54.
Can you provide the consensus rating for SOLENO THERAPEUTICS INC stock?
The consensus rating for SOLENO THERAPEUTICS INC (SLNO) is 85.5556 / 100 . This indicates that analysts generally have a positive outlook on the stock.